Xylocor Therapeutics Inc.

Coronary artery disease and angina

Research activity centers on chronic angina and refractory angina linked to obstructive coronary artery disease, with attention to persistent symptoms despite standard cardiovascular care.

  • Chronic angina
  • Refractory angina
  • Obstructive coronary artery disease

The clinical focus includes symptom relief and reduction of ischemic manifestations in patients with limited treatment options.

Ischemic burden and myocardial perfusion

Trials examine residual ischemic burden and stress-induced perfusion abnormalities in participants with coronary disease, including those at risk for incomplete surgical revascularization.

  • Residual ischemic burden
  • Myocardial perfusion
  • Incomplete revascularization

Interest extends to imaging-based assessment of ischemia and its relationship to ongoing cardiac symptoms.

Left ventricular dysfunction and cardiac function

Another focus is left ventricular dysfunction associated with coronary artery disease, particularly in patients undergoing coronary artery bypass grafting who may remain incompletely revascularized.

  • Left ventricular dysfunction
  • Cardiac contractile function
  • Coronary artery bypass grafting

This area reflects interest in preserving or improving ventricular performance in ischemic heart disease.

Cardiac imaging and exercise-based assessment

Clinical evaluation incorporates stress imaging, cardiovascular magnetic resonance, positron emission tomography, and treadmill exercise testing to characterize ischemia and functional limitation in coronary disease.

  • Cardiovascular magnetic resonance
  • Positron emission tomography
  • Graded treadmill testing

These domains support measurement of ischemic severity, exercise capacity, and cardiac performance in symptomatic patients.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • A Study of Encoberminogene Rezmadenovec Gene Therapy for Patients with Refractory Angina Due to Coronary Artery Disease

    Recruiting

    1 1
    Investigated drugs:
    Belgium Germany Hungary The Netherlands Poland
  • A Study of XC001 Gene Therapy with Bypass Surgery for Patients with Coronary Artery Disease and Weakened Heart Function at Risk for Incomplete Treatment

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany Hungary The Netherlands Poland